James C Czirr - Net Worth and Insider Trading
James C Czirr Net Worth
The estimated net worth of James C Czirr is at least $20 Million dollars as of 2024-04-27. James C Czirr is the 10% Owner of Galectin Therapeutics Inc and owns about 5,922,207 shares of Galectin Therapeutics Inc (GALT) stock worth over $20 Million. Details can be seen in James C Czirr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James C Czirr has not made any transactions after 2024-04-23 and currently still holds the listed stock(s).
Transaction Summary of James C Czirr
James C Czirr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James C Czirr owns 2 companies in total, including Galectin Therapeutics Inc (GALT) , and Mitesco Inc (MITI) .
Click here to see the complete history of James C Czirr’s form 4 insider trades.
Insider Ownership Summary of James C Czirr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-04-23 | director |
| MITI | Mitesco Inc | 2017-02-07 | director |
James C Czirr Latest Holdings Summary
James C Czirr currently owns a total of 1 stock. James C Czirr owns 5,922,207 shares of Galectin Therapeutics Inc (GALT) as of April 23, 2024, with a value of $20 Million.
Latest Holdings of James C Czirr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2024-04-23 | 5,922,207 | 3.45 | 20,431,614 |
Holding Weightings of James C Czirr
James C Czirr Form 4 Trading Tracker
According to the SEC Form 4 filings, James C Czirr has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Galectin Therapeutics Inc is the sale of 25,000 shares on April 23, 2024, which brought James C Czirr around $76,500.
Insider Trading History of James C Czirr
- 1
James C Czirr Trading Performance
GuruFocus tracks the stock performance after each of James C Czirr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James C Czirr is 114.16%. GuruFocus also compares James C Czirr's trading performance to market benchmark return within the same time period. The performance of stocks bought by James C Czirr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James C Czirr's insider trading performs compared to the benchmark.
Performance of James C Czirr
Average Return
-30.64%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.51 | 114.16 | 70.09 | -30.64 | -42.06 | -46.46 |
| Relative Return to S&P 500(%) | 20.78 | 111.91 | 66.05 | -44.08 | -48.15 | -53.09 |
James C Czirr Ownership Network
Ownership Network List of James C Czirr
Ownership Network Relation of James C Czirr
James C Czirr Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
James C Czirr is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, James C Czirr made 1 insider transaction in Galectin Therapeutics Inc (GALT) with a net sale of 25,000. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 12,500 shares made by Kevin D Freeman , and a net purchase of 1,000 shares made by Joel Lewis .
In summary, during the past 3 months, insiders sold 25,000 shares of Galectin Therapeutics Inc (GALT) in total and bought 3,500 shares, with a net sale of 21,500 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 16,898 shares were bought by its insiders, resulting in a net sale of 8,102 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
James C Czirr Mailing Address
Above is the net worth, insider trading, and ownership report for James C Czirr. You might contact James C Czirr via mailing address: 4908 South Ashton Court, Spokane Wa 99223.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
